Comparison Chart Exalenz Bioscience Ltd

Equities

Delayed TEL AVIV STOCK EXCHANGE Other stock markets			5-day change	1st Jan Change
- ^ILa	-.--%		+1.39%	+107.88%

2020	Meridian Bioscience, Inc. completed the acquisition of Exalenz Bioscience Ltd from Mori Arkin and others.	CI
2020	Meridian Bioscience, Inc. agreed to acquire Exalenz Bioscience Ltd from Mori Arkin and others for approximately ILS 170 million.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	EXALENZ BIOSCIENCE LTD	Other Medical Equipment, Supplies & Distribution	-.--%	+1.39%	-	-	-	45.97M	-	-	-